204 related articles for article (PubMed ID: 20049799)
1. Anti-angiogenic perfluorocarbon nanoparticles for diagnosis and treatment of atherosclerosis.
Caruthers SD; Cyrus T; Winter PM; Wickline SA; Lanza GM
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(3):311-23. PubMed ID: 20049799
[TBL] [Abstract][Full Text] [Related]
2. Molecular imaging and therapy of atherosclerosis with targeted nanoparticles.
Wickline SA; Neubauer AM; Winter PM; Caruthers SD; Lanza GM
J Magn Reson Imaging; 2007 Apr; 25(4):667-80. PubMed ID: 17347992
[TBL] [Abstract][Full Text] [Related]
3. Emerging nanomedicine opportunities with perfluorocarbon nanoparticles.
Winter PM; Cai K; Caruthers SD; Wickline SA; Lanza GM
Expert Rev Med Devices; 2007 Mar; 4(2):137-45. PubMed ID: 17359221
[TBL] [Abstract][Full Text] [Related]
4. Combining nanotechnology with current biomedical knowledge for the vascular imaging and treatment of atherosclerosis.
Slevin M; Badimon L; Grau-Olivares M; Ramis M; Sendra J; Morrison M; Krupinski J
Mol Biosyst; 2010 Mar; 6(3):444-50. PubMed ID: 20174673
[TBL] [Abstract][Full Text] [Related]
5. Endothelial alpha(v)beta3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis.
Winter PM; Neubauer AM; Caruthers SD; Harris TD; Robertson JD; Williams TA; Schmieder AH; Hu G; Allen JS; Lacy EK; Zhang H; Wickline SA; Lanza GM
Arterioscler Thromb Vasc Biol; 2006 Sep; 26(9):2103-9. PubMed ID: 16825592
[TBL] [Abstract][Full Text] [Related]
6. 1H/19F magnetic resonance molecular imaging with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Neubauer AM; Caruthers SD; Hockett FD; Wickline SA
Curr Top Dev Biol; 2005; 70():57-76. PubMed ID: 16338337
[TBL] [Abstract][Full Text] [Related]
7. Nanomedicine: perspective and promises with ligand-directed molecular imaging.
Pan D; Lanza GM; Wickline SA; Caruthers SD
Eur J Radiol; 2009 May; 70(2):274-85. PubMed ID: 19268515
[TBL] [Abstract][Full Text] [Related]
8. Clinical applications of perfluorocarbon nanoparticles for molecular imaging and targeted therapeutics.
Tran TD; Caruthers SD; Hughes M; Marsh JN; Cyrus T; Winter PM; Neubauer AM; Wickline SA; Lanza GM
Int J Nanomedicine; 2007; 2(4):515-26. PubMed ID: 18203420
[TBL] [Abstract][Full Text] [Related]
9. Multimodality nanotracers for cardiovascular applications.
Mulder WJ; Cormode DP; Hak S; Lobatto ME; Silvera S; Fayad ZA
Nat Clin Pract Cardiovasc Med; 2008 Aug; 5 Suppl 2():S103-11. PubMed ID: 18641599
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of angiogenesis in nascent Vx-2 rabbit tumors using a novel alpha(nu)beta3-targeted nanoparticle and 1.5 tesla magnetic resonance imaging.
Winter PM; Caruthers SD; Kassner A; Harris TD; Chinen LK; Allen JS; Lacy EK; Zhang H; Robertson JD; Wickline SA; Lanza GM
Cancer Res; 2003 Sep; 63(18):5838-43. PubMed ID: 14522907
[TBL] [Abstract][Full Text] [Related]
11. Nanomedicine opportunities for cardiovascular disease with perfluorocarbon nanoparticles.
Lanza GM; Winter PM; Caruthers SD; Hughes MS; Cyrus T; Marsh JN; Neubauer AM; Partlow KC; Wickline SA
Nanomedicine (Lond); 2006 Oct; 1(3):321-9. PubMed ID: 17716162
[TBL] [Abstract][Full Text] [Related]
12. Polymeric nanoparticulate system: a potential approach for ocular drug delivery.
Nagarwal RC; Kant S; Singh PN; Maiti P; Pandit JK
J Control Release; 2009 May; 136(1):2-13. PubMed ID: 19331856
[TBL] [Abstract][Full Text] [Related]
13. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis.
Emerich DF; Thanos CG
Biomol Eng; 2006 Sep; 23(4):171-84. PubMed ID: 16843058
[TBL] [Abstract][Full Text] [Related]
14. Microfluidic assembly of monodisperse, nanoparticle-incorporated perfluorocarbon microbubbles for medical imaging and therapy.
Seo M; Gorelikov I; Williams R; Matsuura N
Langmuir; 2010 Sep; 26(17):13855-60. PubMed ID: 20666507
[TBL] [Abstract][Full Text] [Related]
15. Towards the use of nanoparticles in cancer therapy and imaging.
Pauwels EK; Erba P
Drug News Perspect; 2007 May; 20(4):213-20. PubMed ID: 17637933
[TBL] [Abstract][Full Text] [Related]
16. Drug-loaded superparamagnetic iron oxide nanoparticles for combined cancer imaging and therapy in vivo.
Yu MK; Jeong YY; Park J; Park S; Kim JW; Min JJ; Kim K; Jon S
Angew Chem Int Ed Engl; 2008; 47(29):5362-5. PubMed ID: 18551493
[No Abstract] [Full Text] [Related]
17. Current status of nanotechnology approaches for cardiovascular disease: a personal perspective.
Buxton DB
Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(2):149-55. PubMed ID: 20049786
[TBL] [Abstract][Full Text] [Related]
18. Multi-functional nanocarriers for targeted delivery of drugs and genes.
Jabr-Milane L; van Vlerken L; Devalapally H; Shenoy D; Komareddy S; Bhavsar M; Amiji M
J Control Release; 2008 Sep; 130(2):121-8. PubMed ID: 18538887
[TBL] [Abstract][Full Text] [Related]
19. Perfluorocarbon nanoemulsions for quantitative molecular imaging and targeted therapeutics.
Kaneda MM; Caruthers S; Lanza GM; Wickline SA
Ann Biomed Eng; 2009 Oct; 37(10):1922-33. PubMed ID: 19184435
[TBL] [Abstract][Full Text] [Related]
20. Perfluorooctylbromide nanoparticles for ultrasound imaging and drug delivery.
Li X; Sui Z; Li X; Xu W; Guo Q; Sun J; Jing F
Int J Nanomedicine; 2018; 13():3053-3067. PubMed ID: 29872293
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
